Universitätsklinikum Freiburg

Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHD (2025) Chatterjee S, Rückert T, Martin I, Michaeli E, Buescher J, Apostolova P, Erny D, et al. Journal article Long-term outcomes of patients with refractory cytopenia of childhood under observation only (2025) Drexler B, Schwarz-Furlan S, Baumann I, Rudelius M, Nöllke P, Lebrecht D, Ramamoorthy S, et al. Journal article Uncovering the Understanding of the Concept of Patient Similarity in Cancer Research and Treatment: Scoping Review (2025) Manuilova I, Bossenz J, Weise AB, Böhm D, Döbel M, Werle SD, Ustjanzew A, et al. Journal article, Review article User-centered design approach to visualize PROMs for molecular tumor boards (2025) Bäcker S, Sedlmayr B, Goldammer M, Schuler K, Zerlik M, Strantz C, Unberath P, et al. Journal article Spatially resolved transcriptomics of benign and malignant peripheral nerve sheath tumors (2025) Bremer J, Franco P, Menstell JA, Tey S, Zajt KK, Popzhelyazkova K, Nolte K, et al. Journal article ERRATUM: Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad (Endocrine-Related Cancer 21:part 4 (567–577) DOI: 10.1530/ERC-14-0254) (2025) Haller F, Moskalev E, Faucz FR, Barthelmeß S, Wiemann S, Bieg M, Assie G, et al. Journal article, Erratum Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study (2025) Mahajan UM, Oehrle B, Goni E, Strobel O, Kaiser J, Grützmann R, Werner J, et al. Journal article ACO/ARO/AIO-22 – External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group (2025) Dapper H, Fleischmann M, Tselis N, Diefenhardt M, Hofheinz RD, Weiß C, Grabenbauer GG, et al. Journal article Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland (2025) Seidel D, Pana ZD, Ebrahimi-Fakhari D, Butzer SK, Mehler K, Reinhold I, Simon A, et al. Journal article Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study (2025) Decker T, Brucker C, Engel A, Fasching P, Göhler T, Jackisch C, Janssen J, et al. Journal article